GSK's Christophe Weber elected as COO of Takeda

Current president, CEO Yasuchika Hasegawa expected to be named chairman, CEO

OSAKA, Japan — Takeda Pharmaceutical Co., the largest drug maker in Japan, has hired the head of GlaxoSmithKline's vaccines division as its COO, Takeda said.

Christophe Weber was elected at the drug maker's board of directors meeting to become COO and candidate as the next CEO. Current president and CEO Yasuchika Hasegawa is expected to be named chairman and CEO.

Weber is currently president and general manager of GSK Vaccines, CEO of GSK Biologicals in Belgium and a member of GSK's global corporate executive team.

"We have extremely high expectations for Mr. Weber's contributions to further enhance and accelerate the implementation of Takeda's global strategy based on his extraordinary and broad business experiences, including an impressive track record in top global pharmaceutical companies," Hasegawa said.

 

Login or Register to post a comment.